Optiscan expects the US FDA to clear its Inspecta veterinary imaging device – without the agency saying a word.

Nyrada shares surge up to 22% after the company announces preclinical cancer drug success Patrys is about to launch a delirium study Mach 7 is in hyperdrive after US client win May 20 marks ...

More News From IDEXX Laboratories, Inc.

AccuSizer®工作站具备仪器控制、数据采集、数理统计分析、出具报告以及权限管理、用户管理、数据安全性、审计追踪和电子签名等功能，完全符合FDA 21 CFR Part11 法规对数据完整性的要求。符合cGMP的管理规范。 内置22种子权限管理，灵活设置，便于更细致化管理 ...

AccuSizer A2000 SIS全自动不溶性微粒检测仪是一款集自动进样、检测、数据处理及自动清洗于一体的注射剂不溶性微粒检测解决方案。该仪器采用先进的光阻法单颗粒光学传感技术(SPOS)，具备0.5 μm – 400 μm的检测范围，并内置各国药典标准。AccuSizer软件符合21CFR Part ...

The first wave of Q1 2026 earnings calls from companies across the security industry's supply chain — manufacturers, distributors, integrators, and service providers — reveals a sector navigating ...

"Increase our full year revenue range to between $4.675 billion to $4.760 billion" and "updating our full year EPS outlook to $14.45 to $14.90 per share" (Executive VP, CFO & Treasurer Emerson). "Our ...

Good morning, and welcome to the IDEXX Laboratories First Quarter 2026 Earnings Conference Call. As a reminder, today's conference is being recorded. Participating in the call this morning are Jay ...

The Company reports revenues of $1,141 million for the first quarter of 2026, an increase of 14% as reported and 11% organic, driven by Companion Animal Group ("CAG") growth of 15% as reported and 12% ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Presbyopia is an age-related eye condition where one of the signs is the reduction in the amplitude of accommodation, resulting in the loss of ability to change the eye's focus from far to near. It is ...